Complimentary commercial content
“We are very excited to be placing our first completed commercial MiQLab system in the Penn Vet [school] microbiology laboratory for their evaluation. This is a tremendous step in delivering our technology into the veterinary market and beyond,” stated Dr. Jack Regan, LexaGene’s CEO and Founder.
Designed for in-clinic, point-of-care, rapid multiplex testing of 20 markers for pathogens and antibiotic resistance, the MiQLab system represents a true breakthrough for veterinary medicine. < link >
Source: LexaGene, November 18, 2020. Link. The university will evaluate the instrument with a range of specimen types. Data collected from the MiQLab will be used to help further determine sensitivity, specificity, and antimicrobial concordance of the test in relation to clinical standards.
Also see: MiQLab™ introductory video. Link. Scroll down for video.